Organization
Medimetriks Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Medimetriks Pharmaceuticals, Inc.
... Medimetriks Pharmaceuticals, Inc.announced today that the U.S. Food and Drug Administration (FDA) approved Xepi(TM) ...
... Medimetriks Pharmaceuticals, Inc. today announced positive results of its Phase 2, multi-center, open-label, maximal ...
... Ltd. (Japan) NEOCUTIS (USA) Merz Pharma GmbH & Co. KGaA (Germany) Medimetriks Pharmaceuticals, Inc. (USA) L'Oréal S.A. (France) Laboratorios Leti SL. (Spain) Kao Corporation (Japan) ...
... BioClarity(TM) Acne Treatment FDA Approves Differin Gel 0.1% for OTC Acne Treatment Medimetriks Submits NDA for Impetigo Treatment Cream Ceramax Cream by IntraDerm Pharmaceuticals Receives ...
... BioCrea, Dart NeuroScience, Carinopharm, CTC Bio, FORUM Pharmaceuticals, Intra-Cellular Therapies, Omeros Corporation, Medimetriks Pharmaceuticals, NuSirt Biopharma, Palobiopharma, Roivant Sciences, Sagene Pharmaceuticals, Tetra Discovery Partners, Tritechbiopharm, ...
... �Medimetriks Pharmaceuticals, Inc.announced today that the U.S. Food and Drug Administration (FDA) has accepted ...
... �Medimetriks Pharmaceuticals, Inc.announced today that it has submitted a New Drug Application (NDA) to ...
... Medimetriks, in collaboration with Otsuka, announces the successful completion of a Phase 2 ...
... to issue a secured loan of up to US$20 million to Medimetriks Pharmaceuticals, Inc. ("Medimetriks") to support its acquisition of the exclusive U.S. development and ...
... to issue a secured loan of up to US$20 million to Medimetriks Pharmaceuticals, Inc. ("Medimetriks") to support its acquisition of the exclusive U.S. development and ...
... Knight Therapeutics Inc. (TSX:GUD) (Knight) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) announced today that Knight has agreed to issue a secured ...
... Otsuka Pharmaceutical Co., Ltd. and Medimetriks Pharmaceuticals, Inc. (based in Fairfield, New Jersey, U.S.) announced that they entered into ...
... Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered into a licensing agreement ...
... Medimetriks Pharmaceuticals, Inc.announced today that its licensor, Ferrer, completed the second Phase III clinical ...
... Directors Andrew Lary and William Resnick to its Board of Directors Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board ...
... Its Sales Force Automation Solution to Drive Growth and Improve Efficiency . Medimetriks, a leading independent specialty pharmaceutical company serving the dermatology and podiatry markets, ...
... Phase III Study for Ozenoxacin has been Initiated by Ferrer . Medimetriks Pharmaceuticals, Inc. Announces that the Second Phase III Study for Ozenoxacin has been ...
... Medimetriks Pharmaceuticals, Inc. Licenses Ozenoxacin, a Novel Antibacterial, from Ferrer . Medimetriks Pharmaceuticals, Inc. Licenses Ozenoxacin, a Novel Antibacterial, from Ferrer. FAIRFIELD, N.J., March 24, ...
Want to see the full history on Medimetriks Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial